Skip to Main Content

WASHINGTON — As drug pricing talks in Congress heated up this week, Democrats negotiated in earnest to get skeptics of their drug pricing policies on board.

With crunch time approaching for talks on a major legislative package containing the cornerstone of President Biden’s domestic agenda, drug pricing policy remained unresolved as lawmakers scramble to get consensus on a complicated, contentious issue. 

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment